Biogen Inc
Pharmaceuticals
BIIB
$ 193 (1.5)%
Share price
$ 28 bn
Market Cap
$ 32 bn
Enterprise Value
Carbon footprint
Primary Climate Goal
Biogen Inc aims to reduce Scope 1 + 2 by 55% by 2032 from a base year 2019
1.5°C
GHG emissions and Carbon intensity
Biogen Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 58 Kt (-9.8 /-14.5% y-o-y). Also positively, carbon intensity dropped to 4.3 t (-0.4 /-8.5% y-o-y).
Biogen Inc's Scope 3 emissions declined to 349 Kt (
The company is committed to reducing Scope 1 + 2 by 55% by 2032 from a base year 2019, which translates into the estimated reduction of -2.3 Kt per annum over the period of FY2021 - FY2032. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.
Copyright © 2022 Exerica. All rights reserved.